Home › agreement
 

Keywords :   


Tag: agreement

Flowserve Signs Supplier Agreement with Advanced Diamond Technologies

2013-04-23 06:00:00| Chemical Processing

Flowserve Corp. has signed an agreement with Advanced Diamond Technologies, Inc. (ADT) to become the exclusive developer and supplier of diamond-coated hard faces for ADTs mechanical seals. When applied to Flowserve base materials, the ultrananocrystalline-structured diamond (UNCD) coating developed by ADT produces an extremely hard surface with significantly improved friction...

Tags: advanced agreement technologies signs

 

Malvern Instruments and NETZSCH Grinding & Dispersing Sign Agreement to Cooperate

2013-04-23 06:00:00| Industrial Newsroom - All News for Today

Malvern, UK– Materials and biophysical characterization company Malvern Instruments Ltd. (Malvern, UK) and NETZSCH Grinding & Dispersing (headquartered in Selb, Germany), a worldwide manufacturer of industrial wet and dry grinding, mixing, dispersing and kneading equipment, have entered into a cooperative marketing agreement. Both organizations serve a broad range of market sectors from pharmaceuticals, ceramics, nano-technology applications, food and surface coatings through to mining ...This story is related to the following:Materials and Material ProcessingParticle Size Testers | Particle Classification | Dispersing Mixers | Grinding Machinery | Materials Characterization Instruments

Tags: sign agreement instruments amp

 
 

Merck Enters Agreement with Bristol-Myers Squibb to Conduct a Phase II Clinical Trial Evaluating Combination of Investigational Oral Candidates MK-5172 and Daclatasvir for Chronic Hepatitis C

2013-04-22 13:30:00| Merck.com - Research & Development News

Dateline City:  WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK) today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial to evaluate the safety and efficacy of a once-daily oral combination regimen consisting of Bristol-Myers Squibbs investigational NS5A replication complex inhibitor daclatasvir and Merck's investigational NS3/4A protease inhibitor MK-5172 for the treatment of chronic hepatitis C virus (HCV) infection, genotype 1. Language:  English Contact HTML:  MerckMedia:Caroline Lappetito, (267) 305-7639orInvestor:Carol Ferguson, (908) 423-4465Justin Holko, (908) 423-5088 Ticker Slug:  Ticker: MRK Exchange: NYSE read more

Tags: c agreement trial combination

 

Samsung Thales Signs Development Agreement With Novelda

2013-04-22 07:39:27| rfglobalnet News Articles

Samsung Thales, Co., Ltd (South Korea) has launched the development program of Vehicle-mounted Land Mine Detector. Samsung Thales’ development will be based on the Novelda NVA6100 Nanoscale Impulse Radar system.

Tags: development agreement samsung signs

 

Genie Energy signs agreement to develop oil shale resources in Mongolia

2013-04-22 01:00:00| Hydrocarbons Technology

Genie Oil Shale Mongolia, a subsidiary of Genie Energy, has signed a five year agreement with the Petroleum Authority of Mongolia (PAM) to explore and evaluate the commercial potential of oil shale resources, on a 34,470km area in central Mongolia.

Tags: resources agreement energy develop

 

Sites : [607] [608] [609] [610] [611] [612] [613] [614] [615] [616] [617] [618] [619] [620] [621] [622] [623] [624] [625] [626] next »